Archive for 2003

NBI On Drugs

NBI On Drugs You won’t recognize the Nasdaq Biotechnology Index (NBI) the next time you see it. It’s undergone a radical change, bulking up to nearly twice its original size by adding 55 more companies to the list. The new Index, which debuted November 24, now consists of 129 firms � and many of the […]



Slowdown casts doubt on biotech offerings

Slowdown casts doubt on biotech offerings After a two-year capital drought, seven biotechnology and life sciences companies made initial public offerings in October and early this month. Now the newly issued stock of six of those companies is underwater — and one, Acusphere Inc. of Watertown, has lost 50 percent of its value since going […]



%d bloggers like this: